Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.

Kurokawa S, Katsuki S, Fujita T, Saitoh Y, Ohta H, Nishikawa K, Sato Y, Sato Y, Ohira K, Yamada M, Kato M.

J Gastroenterol. 2014 Feb;49(2):239-44. doi: 10.1007/s00535-013-0805-2. Epub 2013 Apr 18. Erratum in: J Gastroenterol. 2014 Feb;49(2):373.

PMID:
23595613
[PubMed - in process]
2.

Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.

Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Hirooka Y, Goto H.

J Gastroenterol. 2008;43(4):270-6. doi: 10.1007/s00535-007-2155-4. Epub 2008 May 6.

PMID:
18458842
[PubMed - indexed for MEDLINE]
3.

Aspirin-induced small bowel injuries and the preventive effect of rebamipide.

Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T.

World J Gastroenterol. 2011 Dec 14;17(46):5117-22. doi: 10.3748/wjg.v17.i46.5117.

PMID:
22171147
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Erratum to: A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.

Kurokawa S, Katsuki S, Fujita T, Saitoh Y, Ohta H, Nishikawa K, Sato Y, Sato Y, Ohira K, Yamada M, Kato M.

J Gastroenterol. 2013 Aug 21. [Epub ahead of print] No abstract available.

PMID:
23958865
[PubMed - as supplied by publisher]
5.

Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.

Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa M, Nakagawa S, Shimizu Y, Takeda H, Asaka M.

J Clin Biochem Nutr. 2009 Sep;45(2):248-53. doi: 10.3164/jcbn.09-24. Epub 2009 Aug 28.

PMID:
19794936
[PubMed]
Free PMC Article
6.

Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.

Terano A, Arakawa T, Sugiyama T, Suzuki H, Joh T, Yoshikawa T, Higuchi K, Haruma K, Murakami K, Kobayashi K; Rebamipide Clinical Study Group.

J Gastroenterol. 2007 Aug;42(8):690-3. Epub 2007 Aug 24.

PMID:
17701133
[PubMed - indexed for MEDLINE]
7.

Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY.

Park SH, Cho CS, Lee OY, Jun JB, Lin SR, Zhou LY, Yuan YZ, Li ZS, Hou XH, Zhao HC, Kachintorn U, Kositchaiwat C, Lertkupinit C.

J Clin Biochem Nutr. 2007 Mar;40(2):148-55. doi: 10.3164/jcbn.40.148.

PMID:
18188417
[PubMed]
Free PMC Article
8.

Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers.

Kim HK, Kim JI, Kim JK, Han JY, Park SH, Choi KY, Chung IS.

Dig Dis Sci. 2007 Aug;52(8):1776-82. Epub 2007 Apr 5.

PMID:
17410467
[PubMed - indexed for MEDLINE]
9.

A Randomized, Double-Blind, Placebo-Controlled Study of Rebamipide for Gastric Mucosal Injury Taking Aspirin With or Without Clopidogrel.

Tozawa K, Oshima T, Okugawa T, Ogawa T, Ohda Y, Tomita T, Hida N, Fukui H, Hori K, Watari J, Nakamura S, Miwa H.

Dig Dis Sci. 2014 Mar 23. [Epub ahead of print]

PMID:
24659236
[PubMed - as supplied by publisher]
10.

Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.

Wood RC 3rd, Wyatt JE, Bullins KW, Hanley AV, Hanley GA, Denham JW, Panus PC, Harirforoosh S.

Eur J Pharmacol. 2013 Nov 15;720(1-3):138-46. doi: 10.1016/j.ejphar.2013.10.035. Epub 2013 Oct 24.

PMID:
24365796
[PubMed - in process]
11.

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms.

Mizukami K, Murakami K, Hirashita Y, Hisamatsu A, Ogawa R, Uchida M, Nakagawa Y, Okimoto T, Kodama M, Fujioka T.

J Clin Biochem Nutr. 2012 Nov;51(3):216-20. doi: 10.3164/jcbn.12-27. Epub 2012 Aug 10.

PMID:
23170050
[PubMed]
Free PMC Article
12.

Nonsteroidal anti-inflammatory drug-induced visible and invisible small intestinal injury.

Ito Y, Sasaki M, Funaki Y, Ogasawara N, Mizuno M, Iida A, Izawa S, Masui R, Kondo Y, Tamura Y, Yanamoto K, Noda H, Tanabe A, Okaniwa N, Yamaguchi Y, Kasugai K.

J Clin Biochem Nutr. 2013 Jul;53(1):55-9. doi: 10.3164/jcbn.12-116. Epub 2013 Apr 9.

PMID:
23874071
[PubMed]
Free PMC Article
13.

Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.

Zhang S, Qing Q, Bai Y, Mao H, Zhu W, Chen Q, Zhang Y, Chen Y.

Dig Dis Sci. 2013 Jul;58(7):1991-2000. doi: 10.1007/s10620-013-2606-0. Epub 2013 Feb 28. Review.

PMID:
23456504
[PubMed - indexed for MEDLINE]
14.

Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.

Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N; Rebamipide Ophthalmic Suspension Phase II Study Group.

Ophthalmology. 2012 Dec;119(12):2471-8. doi: 10.1016/j.ophtha.2012.06.052. Epub 2012 Sep 23.

PMID:
23009892
[PubMed - indexed for MEDLINE]
15.

Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin.

Nishida U, Kato M, Nishida M, Kamada G, Yoshida T, Ono S, Shimizu Y, Asaka M.

World J Gastroenterol. 2011 Jan 14;17(2):226-30. doi: 10.3748/wjg.v17.i2.226.

PMID:
21245996
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.

Naito Y, Yoshikawa T, Iinuma S, Yagi N, Matsuyama K, Boku Y, Fujii T, Yoshida N, Kondo M, Sasaki E.

Dig Dis Sci. 1998 Sep;43(9 Suppl):83S-89S.

PMID:
9753232
[PubMed - indexed for MEDLINE]
17.

Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.

Thong-Ngam D, Chayanupatkul M, Klaikeaw N, Rerknimitr R, Mahachai V.

J Med Assoc Thai. 2009 Sep;92(9):1207-12.

PMID:
19772181
[PubMed - indexed for MEDLINE]
18.

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Beh├žet's disease: a randomised, double-blind, placebo-controlled study.

Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y.

Drugs R D. 2003;4(1):19-28.

PMID:
12568631
[PubMed - indexed for MEDLINE]
19.

Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan.

Miwa H, Osada T, Nagahara A, Ohkusa T, Hojo M, Tomita T, Hori K, Matsumoto T, Sato N.

J Gastroenterol Hepatol. 2006 Dec;21(12):1826-31.

PMID:
17074021
[PubMed - indexed for MEDLINE]
20.

Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.

Fujimori S, Takahashi Y, Gudis K, Seo T, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C.

J Gastroenterol. 2011 Jan;46(1):57-64. doi: 10.1007/s00535-010-0332-3. Epub 2010 Oct 6.

PMID:
20924615
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk